FDA expands emergency use of Gilead’s remdesivir in hospitalized COVID-19 patients

FDA expands emergency use of Gilead’s remdesivir in hospitalized COVID-19 patients

Gilead Inc said on Friday the U.S. Food and Drug Administration expanded the emergency use authorization of its experimental antiviral COVID-19 treatment, remdesivir, to allow its use in all hospital…
Read More